Study of Oral Upadacitinib to Assess Change in Disease Activity and Adverse Events in Adult Participants With Ulcerative Colitis or Crohn's Disease
NCT06459297
·
clinicaltrials.gov ↗
COMPLETED
Status
105
Enrollment
INDUSTRY
Sponsor class
Conditions
Ulcerative Colitis
Crohn's Disease
Sponsor
AbbVie